• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Glaukos Corporation Common Stock (NY:GKOS)

    128.52 +6.56 (+5.38%)
    Streaming Delayed Price Updated: 2:36 PM EDT, Jun 9, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Glaukos Corporation Common Stock

    < Previous 1 2
    ...
    4 5 6 7 8 9 10 11 Next >
    News headline image
    Glaukos Comments on the Centers for Medicare and Medicaid Services 2022 Proposed Physician Fee Schedule
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Glaukos Stock Sees Its Relative Strength Rating Improve To Key Above-80 Level ↗
    Glaukos stock had its Relative Strength (RS) Rating upgraded from 78 to 81 Thursday. Is Glaukos on your watchlist? 
    Via Investor's Business Daily
    News headline image
    Glaukos Achieves Pipeline Milestone with Completion of Patient Enrollment in U.S. NDA Phase 3 Clinical Trials for iDose® TR
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Glaukos Announces Australia’s TGA Regulatory Approval for PRESERFLO™ MicroShunt
    From Glaukos
    Via Business Wire
    News headline image
    Glaukos's Earnings: A Preview ↗
    Glaukos (NYSE:GKOS) announces its next round of earnings this Wednesday, May 05. Here is Benzinga's look at Glaukos's Q1 earnings report. Net Income, Earnings, And Earnings Per... 
    Via Benzinga
    News headline image
    Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗
    Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... 
    Via Benzinga
    News headline image
    Glaukos Announces Participation in the William Blair 41st Annual Growth Stock Conference
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Glaukos Expands its PRESERFLO™ MicroShunt Relationship with Santen via New License Agreement
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Glaukos Corp (GKOS) Q1 2021 Earnings Call Transcript ↗
    GKOS earnings call for the period ending March 31, 2021. 
    Via The Motley Fool
    Topics Earnings
    News headline image
    Glaukos Corporation Announces First Quarter 2021 Financial Results
    From Glaukos Corporation
    Via Business Wire
    Why Glaukos's Stock is Up During Today's Session ↗
    Glaukos's Stock Price And Volume Action Glaukos (NYSE:GKOS) is curre... 
    Via Benzinga
    News headline image
    The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues ↗
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)... 
    Via Benzinga
    News headline image
    Glaukos Announces the Release of its 2020 Sustainability Report
    From Glaukos Corporation
    Via Business Wire
    News headline image
    The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs ↗
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 21) Alexion Pharmaceuticals,... 
    Via Benzinga
    News headline image
    Glaukos Announces Global Licensing Agreement Amendment with Intratus, Inc. to Include the Treatment of Presbyopia
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Glaukos Corporation to Release First Quarter 2021 Financial Results after Market Close on May 5
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Benzinga's Top Ratings Upgrades, Downgrades For April 8, 2021 ↗
    Upgrades According to Oppenheimer, the prior rating for Glaukos Corp (NYSE:GKOS) was changed from Perform to Outperform. Glaukos earned $0.02 in the fourth quarter,... 
    Via Benzinga
    < Previous 1 2
    ...
    4 5 6 7 8 9 10 11 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.